Johnson & Johnson Allegedly Pushed Opioids Even After Abuse Became Known; Oklahoma Trial Continues

June 12, 2019 - /PressAdvantage/ - As the Oklahoma trial against Johnson & Johnson for their alleged role in the opioid crisis continues, the state’s star witness told a state judge that the company pressed doctors to prescribe its painkillers even as the potentially fatal addictive threat posed by the drugs became clear more than a decade ago.

The judge, Thad Balkman, is presiding over the non-jury case and will make the final decision in the first trial where a state seeks to hold a drug maker responsible for contributing to the US opioid crisis. Oklahoma is seeking $13 billion in damages from Johnson & Johnson.

Dr. Andrew Kolodny, co-director of opioid policy research at the Heller School for Social Policy and Management at Brandeis University in Waltham, Massachusetts, testified during the third week of the trial. The doctor said that Johnson & Johnson “did everything it possibly could to get doctors to prescribe more and more opioids.”

Oklahoma Attorney General Mike Hunter also claims that Johnson & Johnson’s unit caused a health crisis under the public nuisance theory of law, in an attempt to hold the company accountable for the epidemic. This is traditionally deployed to address real estate disputes over chemical spills, loud noises, etc.

The Oklahoma trial will serve as a preview of how similar claims may play out, as drug makers are facing lawsuits all over the country. Purdue Pharma, the company that created OxyContin is facing thousands of charges across multiple states due to their alleged role in the opioid epidemic. Over 130 Americans are dying from opioid-related overdose every day.

Cities and counties contend that they have spent billions in tax dollars on the societal fall-out from opioid-related overdoses and addictions. This is why they are seeking settlements from large drug manufacturers who allegedly used marketing techniques that downplayed the addictive properties of opioids.

An Oklahoma bench trial that started May 28 could take 2-3 months. A deal may be unlikely during trial unless the state makes concessions, given it would show weakness on the part of Johnson & Johnson.

Kolodny told Balkman that Johnson & Johnson profited even more from the crisis through its ownership of Australian poppy cultivator Tasmanian Alkaloids, which sold its active ingredient to other opioid makers including the company’s former co-defendants in the Oklahoma case, Purdue Pharma and Teva Pharmaceutical.

Johnson & Johnson has since sold the business. In March, Purdue reached a settlement for $270 million. Teva agreed to pay $85 million days before the trial started on May 28.

Johnson & Johnson maintain they legally promoted and sold their Fentanyl-based Duragesic pain patch. They said that the company should not be held responsible for the misdeeds of other companies. Click the link to see Daytona's top rehab placement programs.

Johnson & Johnson’s defense attorney Larry Ottaway noted that other companies had settled when his client had not, saying at the trial’s outset: “when you are right, you fight.”

Another lawyer for Johnson & Johnson said: “the testimony of Dr. Kolodny was filled with rampant speculation and conclusions not derived from facts.”

Kolodny has been active in the study and treatment of opioid addiction for more than a decade. He also worked with the New York City Health Department during the mayoral administration of Michael Bloomberg, founder and majority owner of Bloomberg News parent Bloomberg LP.

Kolodny told Balkman that Johnson & Johson, along with other opioid makers, should not market their products as hard to abuse since all have addictive qualities. They also allegedly used what the US Food and Drug Administration concluded were unreliable studies to tout Duragesic’s benefits as a pain reliever. The company may have also violated federal law by doing head-to-head comparisons of the pain patch’s advantages over Purdue’s OxyContin.

If someone in the family is struggling with opioid or alcohol addiction, it is important to seek help. A combination of medical detox and behavioral therapy can go a long way in the fight against drug abuse. But because every individual is affected by addiction differently, a comprehensive program tailored to their specific needs is necessary. Look for a nearby addiction treatment facility today and find out how drug treatment programs work.

###

For more information about Rehab Near Me: Daytona Beach, contact the company here:

Rehab Near Me: Daytona Beach
+1 863-862-5822

ReleaseID: 60028809

Latest News

China's trade rep says 'external pressures' can help economy

Jun 16, 2019

BEIJING — Chinese media say the country's top trade negotiator has told a forum in Shanghai that "external pressures" can help the economy. Hong Kong's South China Morning Post and mainland Chinese media outlets reported Thursday that Vice Premier Liu He described the pressures that China is currently facing as an "inevitable test." He said the pressures "will help us improve innovation and self-development, speed up reform and opening up, and push forward with high-quality growth." The South China Morning Post says he did not directly reference the U.S.-China trade dispute. The U.S. has accused China of stealing trade secrets...

Asian stocks mostly lower after retreat on Wall Street

Jun 16, 2019

TOKYO — Shares were mostly lower in Asia on Wednesday and Hong Kong's Seng index tumbled 1.7% as thousands continued protests against proposed legislation that many city residents fear could further erode the territory's legal autonomy. Renewed jitters over the trade war between the U.S. and China were weighing on sentiment, pulling shares slightly lower on Wall Street, where benchmarks fell for the first time in six days. Japan's Nikkei 225 index lost 0.2% to 21,154.28 and the Kospi in Seoul shed 0.2% to 2,1087.60. The Shanghai Composite index declined 0.5% to 2,910.82. Australia's S&P ASX 200 edged 0.1% higher...

North Korea says it's fighting swine fever with quarantine

Jun 16, 2019

SEOUL, South Korea — North Korea said Wednesday it is actively fighting the spread of the highly contagious African swine fever weeks after it reported an outbreak near its border with China. The North's official Rodong Sinmun newspaper said workers around the country were proceeding with "airtight" quarantine efforts to prevent the spread of the disease and ensure safety in livestock production. African swine fever has decimated pig herds in China and other Asian countries. It's harmless to people but is fatal to pigs and has no known cure. There's concern in South Korea that the outbreak in the North...

China telecom giant Huawei hints US pressure hurting sales

Jun 16, 2019

SHANGHAI — Huawei's chief strategist said Tuesday the company would have become the world's number one smartphone maker by the year's end if not for "unexpected" circumstances — a hint that pressure from the U.S. may be hurting its sales. The comment by Shao Yang at the Consumer Electronics Show in Shanghai comes as Washington intensifies pressure on other countries to exclude Huawei Technologies from next-generation, or 5G, telecom networks where it actually is considered an industry leader. "If we had not encountered anything unexpected, we would have become number one in the world by the fourth quarter," Huawei's chief...

China's trade surplus soars, as exports unexpectedly edge up

Jun 16, 2019

BEIJING — Chinese exports edged up in May, surprising markets, but analysts say the rebound is likely to be short-lived given higher U.S. tariffs and slowing global growth. China's monthly trade surplus jumped 78% to $41.7 billion, as exports rose 1.1% to $213.8 billion and imports fell 8.5% to $172.2 billion, the Chinese customs agency said Monday. The fall in imports reflects weak domestic demand, analysts said. The rise in exports came despite a worsening trade war with the United States in which both countries have raised tariffs on each other's products. "While exports rose in May, weaker global demand...

Subscribe To Our Newsletter